August 28, 2026 (MLN): Abbott Laboratories (Pakistan) Limited (PSX: ABOT) reported a 17% increase in its net profit for the half-year ended June 30, 2026 (1HCY26), reaching Rs4.14bn compared to Rs3.54bn in the corresponding period last year.
Reflecting this solid bottom-line growth, basic and diluted earnings per share (EPS) for the six-month period improved to Rs42.29, up from Rs36.19 in 1HCY25.
The primary catalyst behind the financial expansion was a combination of steady local revenue growth and expanded gross margins.
Net sales grew by 4% year-on-year to Rs38.03bn, up from Rs36.41bn in 1HCY25, as a 6% increase in local sales (Rs37.15bn) offset a 41% decline in export sales (Rs875.69m).
Meanwhile, the cost of sales decreased slightly by 1% to Rs23.58bn, enabling gross profit to expand 15% to Rs14.45bn compared to Rs12.61bn in the prior year.
On the operational front, overheads expanded to support distribution and administration.
Selling and distribution expenses rose 11% to Rs6.15bn, administrative expenses grew 22% to Rs776.09m, and other charges increased 7% to Rs887.41m.
Supported by a 43% boost in "other income", operating profit before finance costs rose 20% to Rs7.24bn.
Below the operating line, finance costs remained minimal, dropping 5% to Rs35.64m. Although the company absorbed a minimum tax differential levy of Rs159.45m, profit before taxation grew by 17% to reach Rs7.04bn.
The company absorbed an 18% higher net income tax expense of Rs2.90bn for the six-month period.
Supported by local top-line strength, gross margin expansion, and higher secondary income, Abbott Laboratories (Pakistan) Limited securely closed the half-year with its net profit reaching Rs4.14bn.
|
STATEMENT OF PROFIT OR LOSS FOR THE HALF YEAR ENDED JUNE 30, 2026 (Rs.000) |
|||
|
Description |
2026 |
2025 |
change % |
|
Sales - net |
|||
|
Local |
37,150,866 |
34,913,845 |
6.4% |
|
Export |
875,685 |
1,493,944 |
-41.4% |
|
(Total net sales subtotal) |
38,026,551 |
36,407,789 |
4.4% |
|
Cost of sales |
(23,576,445) |
(23,792,889) |
-0.9% |
|
Gross Profit |
14,450,106 |
12,614,900 |
14.5% |
|
Selling and distribution expenses |
(6,145,400) |
(5,527,267) |
11.2% |
|
Administrative expenses |
(776,092) |
(638,195) |
21.6% |
|
Other charges |
(887,408) |
(826,334) |
7.4% |
|
Other income |
593,980 |
416,745 |
42.5% |
|
Operating profit before finance costs |
7,235,186 |
6,039,849 |
19.8% |
|
Finance costs |
(35,643) |
(37,704) |
-5.5% |
|
Profit before minimum tax differential and income tax |
7,199,543 |
6,002,145 |
19.9% |
|
Minimum tax differential |
(159,446) |
- |
|
|
Profit before income tax |
7,040,097 |
6,002,145 |
17.3% |
|
Current tax |
(3,075,855) |
(2,647,573) |
16.2% |
|
Deferred tax |
175,989 |
188,600 |
-6.7% |
|
(Income tax subtotal) |
(2,899,866) |
(2,458,973) |
17.9% |
|
Profit for the period |
4,140,231 |
3,543,172 |
16.9% |
|
Earnings per share - basic and diluted (Rupees) |
42.29 |
36.19 |
16.9% |
Read the full story on the original publisher’s website.
Open original article